Search for stocks /

UltraTech Cement:₹85,775 Cr ARR. 10.9% ROCE. Buying Time Before the Capacity Tsunami Hits.

UltraTech Cement Q3 FY26 | EduInvesting
Q3 FY26 Results · India’s Largest Cement Producer

UltraTech Cement:
₹85,775 Cr ARR. 10.9% ROCE.
Buying Time Before the Capacity Tsunami Hits.

India’s biggest cement player just posted ₹21,830 crore in quarterly revenue—a 22.8% jump—while demand hovers at 6-7% growth and competition builds new capacity faster than customers can consume it. The math is not adding up. Yet.

Market Cap₹3,52,834 Cr
CMP₹11,987
P/E Ratio45.4x
Div Yield0.65%
ROCE10.9%

India’s Cement Champ: Size Doesn’t Always Mean Profit

  • 52-Week High / Low₹13,110 / ₹10,356
  • Q3 FY26 Revenue₹21,830 Cr
  • Q3 FY26 PAT₹1,729 Cr
  • Quarterly EPS₹58.55
  • Annualised EPS (Q3×4)₹234.20
  • Book Value₹2,444
  • Price to Book4.90x
  • Dividend Yield0.65%
  • Debt / Equity0.35x
  • Annual Revenue (TTM)₹85,775 Cr
The Auditor’s Hot Take: UltraTech is staring down a binary future. Q3 showed 22.8% revenue growth on organic + acquisitions, but ROCE of 10.9% is what a savings account earns while sleeping. Meanwhile, the company is committing ₹28,000–₹30,000 crore capex through 2027 to add ~60 MTPA of new capacity. India’s cement demand growth? A sleepy 6–7% per year. The math only works if the industry stays undersupplied for the next decade. Spoiler alert: it won’t.

The Comfortable Monopoly That’s About to Get Very Uncomfortable

Let’s talk about UltraTech Cement. India’s largest cement maker. 28% of India’s grey cement installed capacity. 3rd largest cement company globally, excluding China. Commands the infrastructure boom like a king who just realized the kingdom is rapidly filling with queens and peasants who know how to fight.

For decades, cement was a boring, cash-guzzling business with captive demand: if you needed concrete, you needed cement, and UltraTech’s distribution network made it hard to avoid. Simple value extraction. Boring returns. Happy shareholders on dividend days.

Then something changed. In 2023–2024, UltraTech went on an acquisition spree. Kesoram. India Cements. Suddenly, capacity went from ~150 MTPA to ~200 MTPA. Brand conversions are underway. Management is giddy about synergies and margin uplift from cost-improvement capex. The concalls are increasingly audacious: “South will be the new north.” “We expect capacity utilization >90%.” “Q4 will be robust.”

All of this against the backdrop of an industry adding capacity at 12+ MTPA annually, while demand grows at 6–7%. Do the math. UltraTech is a sprawling, complex acquisition machine trying to pretend that adding more capacity into a slowly-growing market is a strategy rather than a desperate cope.

Let’s pick this apart. With data. With sarcasm. With the kind of brutally honest analysis your RM will never offer you.

Concall Excerpt (Jan 2026): “Demand is the most important aspect of our business. Everything else becomes secondary.” Yet management expects >90% utilization. Make it make sense.

Mining + Burning + Crushing + Distributing = Profit?

UltraTech is a vertically integrated cement producer. Mine limestone from captive quarries. Heat it with coal (increasingly green power). Grind it into clinker. Mix with supplementary materials like fly ash and slag. Package into bags or sell in bulk. Distribute through 34,500 dealers and 103,200 retailers across 30,000 destinations. Command 28% market share. Rinse. Repeat. Go broke trying.

The business is straightforward: high capex, low margins, commodity pricing, working capital hell, and an obsession with utilization rates that borders on pathological. Every quarter, management leads with “capacity utilization is up.” As if running furnaces harder is a feature, not a sign of desperation.

Product mix is aging. Grey cement still dominates at 80% of revenue. Ready-mix concrete (RMC) is growing but at 9% of revenue, it’s more garnish than main course. White cement, overseas operations, and specialty products are rounding errors. The company is trying to build adjacencies (RMC footprint in 163 cities, cables & wires project launching Oct–Dec ’26), but these are long-term bets in a market obsessed with quarterly returns.

Distribution is the moat. But distribution of a commodity is like owning a great relationship with someone who can get you any brick—nice to have, but not defensible when five other suppliers show up with trucks.

Market Share28%Grey Cement
Installed Cap~158 MTPADomestic Grey
Utilization~75%Q3 FY26
RMC Presence163 CitiesExpanding
💬 Here’s the uncomfortable question: If UltraTech has 28% market share and is still struggling with 10.9% ROCE, what does that tell you about the industry’s fundamental returns? Drop your thoughts.

Q3 FY26: The Smoke and Mirrors

Result type: Quarterly Results  |  Q3 FY26 EPS: ₹58.55  |  Annualised EPS (Q3×4): ₹234.20  |  FY25 Full-Year EPS: ₹260.11

Source table
Metric (₹ Cr) Q3 FY26
Dec 2025
Q3 FY25
Dec 2024
Q2 FY26
Sep 2025
YoY % QoQ %
Revenue21,83017,77919,607+22.8%+11.3%
Operating Profit3,9112,8933,089+35.2%+26.6%
OPM %18%16%16%+200 bps+200 bps
PAT1,7291,3631,238+26.9%+39.7%
EPS (₹)58.5547.0941.79+24.4%+40.0%
The Numbers Behind the Noise: Q3 FY26 revenue up 22.8% YoY — but wait. UltraTech had zero Kesoram/India Cements for most of Q3 FY25. The organic growth is probably closer to ~9–10%. Operating leverage and acquisition impact hide a slower underlying business. PAT up 26.9%, but that includes a ₹88 crore labour code one-time charge (management disclosed). Strip that, and the uplift is more muted. Current P/E of 45.4x is absurdly stretched for a 10.9% ROCE business. Market is pricing in a margin paradise that may never arrive.

Is UltraTech Worth ₹12,000 Per Share? Let’s Do the Math.

Method 1: P/E Based

FY25 full-year EPS = ₹260.11. Annualised Q3 FY26 EPS (normalized for one-time charges) = ~₹230–240. Cement sector median P/E = 27.8x. UltraTech’s justified premium (if any) = 1.3x–1.5x sector. Fair P/E band: 24x–28x (conservative) to 32x–42x (optimistic).

Range: ₹6,240 – ₹10,080 (using ₹260 EPS)

Method 2: EV/EBITDA Based

TTM EBITDA (FY25) = approx. ₹16,013 Cr (using OPM 19% on ₹85,775 Cr + other income). Current EV = ₹3,76,761 Cr → EV/EBITDA = 23.5x. Cement peers trade at 10x–15x. UltraTech at 23.5x is expensive, but let’s allow for re-rating to 12x–16x for quality.

EV range (12x–16x): ₹1,92,156 Cr – ₹2,56,208 Cr → Per share (assuming ₹25,215 Cr net debt):

Range: ₹5,650 – ₹7,850

Method 3: DCF Based (Conservative)

Base OCF: ~₹10,673 Cr (FY25). Growth: 4–6% for 5 years (industry growth, not optimism). Terminal growth: 2.5%. WACC: 9.5%.

→ PV of 5-year FCFs at 9.5%: ~₹50,000 Cr
→ Terminal Value (2.5% growth / 7% cap rate): ~₹150,000 Cr
→ Total EV: ~₹200,000 Cr (add net debt ₹25,215 Cr)

Range: ₹7,600 – ₹8,900

Fair Min: ₹6,000 CMP: ₹11,987  |  DCF Mid: ₹8,250 Fair Max: ₹10,000
CMP ₹11,987 DCF Mid ₹8,250
⚠️ EduInvesting Fair Value Range: ₹6,000 – ₹10,000. Current market price of ₹11,987 sits ~20–45% above the high end of fair value. This range is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making financial decisions.

M&A Hangover, Leadership Shuffles, and Capex Ambitions

🔴 The Capacity Expansion Trap

UltraTech is committed to ₹28,000–₹30,000 crore capex through 2027 to add ~60 MTPA of new capacity, reaching 235–240 MTPA by FY28. Q4 FY26 expected to add 8–9 MTPA. FY27: +12 MTPA. FY28: balance of the announced program. Meanwhile, management says demand growth is 6–7% annually. Simple math: they’re building capacity at 2–3x the rate demand is growing. This works only if competitors don’t add capacity. They are. Aggressively. The industry is collectively setting itself up for a margin-crushing party by FY28.

⚠️ Acquisition Integration Headwinds

  • • Kesoram: Brand conversion 69% → now >70% (as of Jan 2026)
  • • India Cements: Brand conversion 58% (Dec 2025) → ~55% (CFO also cited)
  • • Cost-improvement capex underway; benefits to show Jan–Mar ’27 Q4
  • • India Cements EBITDA/ton: ₹400 in Q3 → Path to ₹1,000/ton by Q4 FY27
  • • Non-core monetization: Sold Indonesia coal mining company; ≥₹500 Cr more potential

✅ The Demand Narrative

  • • Infrastructure intensity quantified: 350–900 MT/km for roads; 17,000–19,000 MT/km for underground metro
  • • Cited pipelines: UP metro (1,575 km through 2047), Maharashtra sea link (₹58,000 Cr), Delhi Metro (₹12,000 Cr)
  • • Management sees “multi-year cement intensity” and “secondary demand” (housing, jobs)
  • • South India expected to be “new north” in FY26—major tailwind bet
  • • Q3 demand growth: 9–10% all-India (CFO caveat: “Don’t hold me to it”)

⚠️ Management Shuffle & Regulatory Noise

  • • Jayant Dua appointed MD (Designate) from 1 Apr 2026; MD term 1 Jan 2027–31 Dec 2030 (pending shareholder approval)
  • • Multiple GST demands and penalties (~₹300+ Cr in demands across various orders); company contesting all
  • • Fitch affirmed BBB- IDRs; Moody’s affirmed Baa3 (both stable outlook)

✅ Product & Adjacency Expansion

  • • Cables & Wires: ₹500 Cr orders placed, ₹197 Cr spent, ~30% team onboarded, product launch Oct–Dec ’26
  • • RMC footprint: 321 plants in 134 cities, growing rapidly (3% of total cement volumes)
  • • Premium cement share: 36% of portfolio
  • • Green power: Currently ~41%, target 60% by FY27/H1 FY28
The Real Story: Capacity additions across Q4–FY27 will push UltraTech’s total to 199 MTPA by end-FY26. Industry utilization is already tightening (management expects >90% in Q4). But as more capacity comes online industry-wide, pricing power evaporates. This is a three-to-five year story. The next three quarters will be euphoric. Then reality hits.

Is the Fort Still Standing?

Source table
Item (₹ Cr) Sep 2025 Mar 2025 Mar 2024 Mar 2023
Total Assets1,37,3051,33,6321,00,79791,380
Net Worth (Eq + Reserves)72,03370,70760,22854,325
Borrowings25,21524,10211,40311,058
Other Liabilities40,05838,82329,16725,998
Total Liabilities1,37,3051,33,6321,00,79791,380
💸 Debt Ballooning
Borrowings jumped from ₹11.4 Cr (Mar 2024) to ₹25.2 Cr (Sep 2025). That’s a 121% increase in 18 months. Kesoram + India Cements acquisitions + capex are being debt-funded. Net debt/EBITDA at 1.08x (management says path to 1.0x and 0.8–0.9x by FY26 end). Sounds optimistic. Let’s wait and see.
🏗️ Asset Inflation
Total assets grew 50% in two years. CWIP (capital work-in-progress) at ₹7,206 Cr (Sep 2025) — all those new furnaces and plants under construction. Fixed assets at ₹95,930 Cr. Depreciation will be savage for the next 10 years.
📦 Working Capital Management
Days payable at 248 days. Days inventory at 255 days. Debtors at 28 days. Negative working capital of -64 days in FY25 is good—but acquisition accounting is masking the picture.

Sab Capex Mein Gaaya, Dividend Kahan Se Ayega?

Source table
Cash Flow (₹ Cr)FY23FY24FY259M FY26
Operating CF+9,069+10,898+10,673~8,000
Investing CF-7,188-8,789-15,836-7,000 to -7,200
Financing CF-1,631-1,926+5,076TBD
Net Cash Flow+250+183-86~-1,000 to -200
✅ ₹10,673 Cr Operating CF (FY25)The only bright light. OCF has been stable at ₹9,000–11,000 Cr for three years. Management funnels this entirely into capex and debt service. Nothing left for shareholders except token dividends (0.65% yield).
⚠ -₹15,836 Cr Investing CF (FY25)FY25 was brutal. Kesoram acquisition + India Cements acquisition + organic capex = ₹15.8 Cr outflow. 9M FY26 spending is ₹7,000–7,200 Cr. Q4 expected ₹2,000–2,500 Cr. Full-year guidance: ~₹9,500–10,000 Cr. That’s capex eating 90%+ of OCF.
📊 Financing CF Flip (+₹5,076 Cr in FY25)All debt issuance. The company is borrowing heavily to fund the acquisition and capex binge. This works only if ROCE improves materially post-integration. No guarantee.
⚠ Zero Shareholder Returns ComingWith capex at ₹9,500–10,000 Cr annually and OCF at ~₹10,500 Cr, there’s almost nothing left for dividends. Current yield of 0.65% is a charitable joke. Expect no dividend growth for 2–3 years.

Profitability Ratios That Would Make a PE Investor Cry

ROE9.29%3yr avg: 10.4%
ROCE10.9%Below Cost of Capital
P/E45.4xSector: 27.8x
OPM18.7%Decent, Not Great
Debt / Equity0.35xRising Fast
EV/EBITDA23.5xRich Valuation
Current Ratio0.69xTight Liquidity
Int. Coverage6.48xHealthy, Not Bulletproof
The Uncomfortable Truth: ROE of 9.29% means UltraTech is destroying shareholder value on a risk-adjusted basis. ROCE of 10.9% is below the cost of equity (11–12%). The company is adding capacity at a ROCE < cost of capital. This is value destruction, not creation. A P/E of 45.4x is pricing in a margin and ROCE expansion that requires either (a) competitors to stop adding capacity (unlikely), or (b) demand to grow faster than historical trends (we see no evidence). The market is pricing in a happy ending that the cement industry rarely delivers.

Annual Trends — FY22 to FY25: The Stagnation Story

Source table
Metric (₹ Cr)FY22FY23FY24FY25
Revenue52,59963,24070,90875,955
Operating Profit11,51410,62012,97912,797
OPM %22%17%18%17%
PAT7,3345,0737,0046,040
EPS (₹)254.42175.41242.65204.94
Revenue CAGR (3yr)+13.0%
PAT CAGR (3yr)-5.37%
OPM Trend22→17%Compression

Here’s the killer: Revenue up 13% CAGR over three years, but PAT down 5.37% CAGR. Expenses are growing faster than revenue. Operating margins compressed from 22% to 17% (FY22 to FY25). FY25 EPS of ₹204.94 is lower than FY22’s ₹254.42. Inflation, acquisition overheads, and integration costs are eating the business alive. Yet the market buys at 45.4x P/E. Only in India.

UltraTech vs The Competition: Size Doesn’t Mean Smarts

Grasim IndsP/E 40.1xROCE 7.5%₹1,84,942 Cr
Ambuja CementsP/E 30.0xROCE 10.5%₹1,15,360 Cr
Shree CementP/E 50.1xROCE 6.7%₹89,755 Cr
ACCP/E 11.2xROCE 17.4%₹28,199 Cr
Source table
CompanyQtr Revenue (₹ Cr)Qtr PAT (₹ Cr)P/EROCE %Div Yield %
UltraTech21,8301,72945.4x10.9%0.65%
Grasim Inds44,3122,23340.1x7.5%0.37%
Ambuja Cements10,27736730.0x10.5%0.43%
Shree Cement4,80126850.1x6.7%0.44%
ACC6,48340411.2x17.4%0.50%

The big story: ACC trades at 11.2x P/E with 17.4% ROCE. UltraTech at 45.4x with 10.9% ROCE. Ambuja at 30x with 10.5% ROCE is the goldilocks option—but Ambuja is much smaller. UltraTech’s premium is not justified by returns. Grasim’s 7.5% ROCE is terrible, yet investors pay 40x. The entire sector is overvalued relative to intrinsic returns.

Who Owns This Sprawling Cement Empire?

  • Promoters (Grasim+Birla group)59.28%
  • Public14.66%
  • DIIs17.45%
  • FIIs14.44%

Promoter: Grasim Industries / The Aditya Birla Group

Grasim holds 56.11% directly. Then you’ve got PIIC (1.5%), PT Indo Bharat Rayon (0.78%), Hindalco (0.43%), plus a constellation of Birla family HUFs and trusts. Total promoter grip: 59.28%. The Birla group’s cement strategy is to control India’s largest producer and use it as a cash-generation machine to fund other Birla conglomerate adventures. This isn’t capital efficiency; it’s capital deployment at a conglomerate level.

FIIs Hold 14.44% & DIIs 17.45%

Foreign investors own ~₹50,000 Cr of the company. DIIs (mostly insurance funds and mutual funds) own another ₹61,500 Cr. Both are betting on India’s infrastructure narrative and accepting a 10.9% ROCE because growth statistics look sexy. The moment consensus shifts to “cement industry is over-capacity,” FII flows reverse. Shareholders beware.

Pledge Status: 0.00% — clean ownership structure. No. of Shareholders: 4.12 lakh (growing retail participation). The retail investor is increasingly buying into a story of “India’s cement boom.” The reality is more complex.

The Boring But Critical Stuff

✅ The Clean Sheet

  • ✓ Clean audit history — no material qualifications
  • ✓ Credit ratings stable (Fitch BBB-, Moody’s Baa3)
  • ✓ Interest coverage at 6.48x — debt is manageable
  • ✓ Regular quarterly concalls and investor engagement
  • ✓ Board meetings scheduled (27 Apr 2026 for FY26 audited results)
  • ✓ No promoter pledges — ownership clean

⚠️ Watch List

  • ⚠ Multiple GST demands (~₹300+ Cr across various orders); company contesting
  • ⚠ Jayant Dua appointed MD (Designate); takeover 1 Jan 2027
  • ⚠ Trading window closure: 1 Apr–29 Apr for FY26 results announcement
  • ⚠ Debt levels rising fast (₹25.2 Cr Sep 2025 vs ₹11.4 Cr Mar 2024)
  • ⚠ Capex-heavy phase for next 2 years will suppress dividend growth
  • ⚠ GST compliance disputes are recurring headaches

Indian Cement: The Commodity Game Where Everyone Loses Eventually

The Indian cement industry is a textbook case of how easy it is for a “must-have commodity” to become a low-return trap. Every time demand looks robust, another player announces capacity additions. Every time margins expand, competition floods in. Every time utilization tightens, prices rise, demand growth falls, and utilization drops. It’s a hamster wheel disguised as a business.

🏗️ The Capacity Addiction Problem

India’s cement installed capacity is expected to grow from ~500 MTPA (today) to 600+ MTPA by FY28. Demand is growing at 6–7% annually. That’s 40 MT of demand growth vs 100+ MT of capacity additions. The industry is collectively building to a utilization cliff. Management at every company knows this. Yet they all add capacity because the alternative — market share loss — is terrifying. This is a textbook prisoners’ dilemma.

💰 Infrastructure Pipeline is Real, But…

UltraTech management cited ₹16,000 Cr Punjab roads, ₹58,000 Cr Maharashtra sea link, ₹70,000 Cr Bihar Ganga roads, UP metro 1,575 km. These are real projects. Cement intensity calculations (350–900 MT/km for roads, 17,000–19,000 MT/km for underground metro) are plausible. But infrastructure cycles are lumpy. Q1 sees demand spikes, Q3 demand dries up. And after 2027, as these mega-projects wrap, what happens to cement demand? Management has no answer because it’s a management blind spot.

🌍 Exports: A Red Herring

UltraTech exports minimal cement (offshore subsidiaries in UAE, Bahrain, Sri Lanka). Exports represent <2% of revenue. In a domestic over-capacity scenario, exporting becomes a race to the bottom (low-margin, high-freight). Overseas markets have their own dominant players. This is not a growth escape hatch.

⚠️ RMC & Adjacent Businesses: The Margin Trap

UltraTech is expanding RMC (ready-mix concrete) across 163 cities, with plans to drive it from 3% to 5–7% of volume mix. RMC is supposed to be “higher margin,” but in practice, it’s a service business with tight margins, logistics complexity, and customer concentration risk. The same story plays for cables & wires (launching Oct–Dec ’26). These adjacencies are good for growth metrics in investor pitches. They’re terrible for ROCE.

✅ Green Power & Sustainability: Real Progress

Management’s green power target of 60% by FY27/H1 FY28 (from 41% current) is credible and CapEx-efficient. Renewable sourcing also insulates from volatile coal prices. This is a genuine competitive advantage. But it’s not enough to offset the capacity over-supply problem.

Competitive Landscape: Ambuja and ACC (LafargeHolcim subsidiaries) are well-positioned. Shree Cement operates in the premium/southern niche with good ROCE (6.7%, actually falling) but small scale. Grasim is a mess (7.5% ROCE). Regional players (JK Cements, Dalmia Bharat) are scrappy and lean. UltraTech’s size is a burden in a low-growth, over-capacity market. It’s too big to escape to niche markets, too slow to move pricing, and saddled with integration costs from aggressive M&A.

Macro Tailwinds vs Headwinds: Tailwinds: Government capex in roads, metros, irrigation. Infra spending cycle is intact through 2026–27. Tailwinds: Urbanization and housing demand in Tier-II and Tier-III cities. Headwinds: Capacity over-supply by FY28. Headwinds: Pricing power erosion as utilization drops. Headwinds: Labour cost inflation (new labour code). Headwinds: Working capital crunch as players try to maintain volumes at lower prices.

💬 Here’s the uncomfortable question nobody asks: In an over-capacity industry, why do investors pay premium P/E multiples? The answer: because India’s infrastructure narrative is so compelling that people ignore the math. But math always wins. Drop your view on when the cement cycle turns.

The Hard Truth About Scale Without Returns

⚖️

UltraTech Cement is India’s largest cement producer by market cap and installed capacity. It’s also a textbook case of how being the biggest in a slow-growth, over-capacity industry can destroy value rather than create it. ₹85,775 Cr annual revenue. 10.9% ROCE. 45.4x P/E valuation. ₹25,215 Cr debt. Zero dividend growth for the next 2–3 years. This is a company in structural transition, and the market is pricing in a fairy-tale ending that the Indian cement industry rarely delivers.

Q3 FY26 Execution: Revenue up 22.8% YoY (but organic growth closer to 9–10% once you strip Kesoram/India Cements contribution). Operating leverage from volume growth and mix improvement. Management signaling utilization >90% in Q4. Cost control measures delivering: lead distance reduced, clinker conversion factor improved, renewable power ramping. These are all real, but they’re table-stakes — not growth accelerators.

The Capacity Trap: UltraTech is committed to ₹28,000–₹30,000 Cr capex through FY28 to add 60 MTPA of capacity, reaching 235+ MTPA. The industry is simultaneously adding 100+ MTPA. Demand growth is 6–7%. This is a recipe for utilization compression and pricing pressure by FY28. Management’s rebuttal: infrastructure pipeline is large. True. But infrastructure cycles are lumpy, and by FY29, these mega-projects will have wrapped. Then what?

M&A Execution Risk: Kesoram and India Cements acquisitions are still in the integration phase. Brand conversion is progressing (70%+ for Kesoram, ~55% for India Cements), but cost-improvement capex benefits don’t show until Q4 FY27. Management’s target: India Cements EBITDA/ton to ₹1,000/ton by Q4 FY27 (vs ₹400/ton in Q3). That’s a 150% uplift. Achievable? Possibly. But it requires flawless execution, rising volumes, and pricing stability. The industry will likely deny the latter two.

Valuation Verdict: Fair value range of ₹6,000–₹10,000 vs CMP of ₹11,987 suggests the stock is 20–45% overvalued. A P/E of 45.4x is absurd for a 10.9% ROCE business in a low-growth, over-capacity market. Peers like Ambuja (P/E 30x, ROCE 10.5%) and ACC (P/E 11.2x, ROCE 17.4%) offer better value. UltraTech’s premium is unjustified unless ROCE improves to 14–15%+ (unlikely in current market) or dividend yields expand materially (blocked by capex plans).

Risk/Reward: Downside risks: capacity over-supply by FY28, pricing compression, slower-than-expected integration benefits, cost inflation, lower dividend payout, further debt issuance to fund capex. Upside catalysts: infrastructure super-cycle runs longer than expected, M&A synergies exceed guidance, South India margin inflection, successful RMC/cables adjacency expansion, FII appetite for “India growth story” persists.

✓ Strengths

  • 28% market share — largest cement producer in India
  • ~235 MTPA total capacity by FY28 (domestic grey 158 MTPA as of Oct 2024)
  • Vertical integration: captive limestone mines + coal blocks
  • Distribution network: 34,500 dealers, 103,200 retailers, 30,000+ destinations
  • Green power at 41%, targeting 60% by FY27/H1 FY28
  • Adjacent businesses: RMC (163 cities), cables & wires launch planned

✗ Weaknesses

  • ROCE of 10.9% — below cost of equity, destroying value on new capex
  • ROE of 9.29% — mediocre returns on shareholder capital
  • Operating margins compressed from 22% (FY22) to 17% (FY25)
  • Debt levels rising fast (₹25.2 Cr Sep 2025 vs ₹11.4 Cr Mar 2024)
  • M&A integration ongoing; cost-improvement capex benefits delayed to Q4 FY27
  • Dividend yield at 0.65% — essentially zero return to shareholders

→ Opportunities

  • Infrastructure pipeline: roads, metros, irrigation, housing (multi-year intensity)
  • South India demand inflection (management thesis: “South will be new north”)
  • RMC adjacency expansion from 3% to 5–7% of volume mix (higher margin potential)
  • Cables & wires launch (Oct–Dec ’26) — premium adjacency
  • Cost synergies from Kesoram/India Cements integration (₹900+ Cr annual run-rate potential)
  • Land monetization from India Cements (~₹500 Cr opportunity identified)

⚡ Threats

  • Industry capacity over-supply by FY28 (100+ MTPA additions vs 6–7% demand growth)
  • Pricing pressure as utilization drops below 85% (industry threshold)
  • Slower-than-expected infrastructure demand post-2027 (project completion cycle)
  • Cost inflation: coal, pet coke, labour (new labour code), energy
  • FII/DII redemptions if growth narrative breaks or dividend yields shrink further
  • GST compliance disputes (₹300+ Cr in current demands, though being contested)
  • Competitive intensity from Ambuja, ACC, Shree Cement, and regional players

UltraTech Cement is a sprawling, complex, debt-funded acquisition machine masquerading as an operational excellence story.

The company has real assets (distribution, vertical integration, brand equity), real execution (Q3 revenue and operating leverage grew as promised), and real management capability (cost reduction programs delivering results). What it does not have is a defensible path to earnings growth that justifies a 45x P/E multiple in an industry that’s about to face capacity over-supply like never before.

For investors seeking exposure to India’s infrastructure boom, UltraTech is the obvious choice. For investors seeking value and returns, the story breaks apart. A cement company with 10.9% ROCE should trade at 8–12x P/E, not 45x. The gap between valuation and intrinsic returns is too wide to ignore.

⚠️ EduInvesting Fair Value Range: ₹6,000 – ₹10,000. Current market price of ₹11,987 represents a 20–45% premium to fair value. This analysis is strictly for educational purposes and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making any financial decision.
error: Content is protected !!